These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35525262)

  • 61. Beneficial effect of ticagrelor on microvascular perfusion in patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
    Wang X; Li X; Wu H; Li R; Liu H; Wang L; Bai S; Zhang L; Chen T; Liu J; Li Q; Du R
    Coron Artery Dis; 2019 Aug; 30(5):317-322. PubMed ID: 30614823
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Combined assessment of left ventricular end-diastolic pressure and ejection fraction by left ventriculography predicts long-term outcomes of patients with ST-segment elevation myocardial infarction.
    Saito D; Nakanishi R; Watanabe I; Yabe T; Okubo R; Amano H; Toda M; Ikeda T
    Heart Vessels; 2018 May; 33(5):453-461. PubMed ID: 29143103
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
    Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
    [No Abstract]   [Full Text] [Related]  

  • 64. The diagonal branches and outcomes in patients with anterior ST- elevation myocardial infarction.
    Zhang S; Deng X; Yang W; Xia L; Yao K; Lu H; Ge L; Shen L; Sun A; Zou Y; Qian J; Ge J
    BMC Cardiovasc Disord; 2020 Mar; 20(1):108. PubMed ID: 32131738
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Global longitudinal strain by feature tracking for optimized prediction of adverse remodeling after ST-elevation myocardial infarction.
    Reindl M; Tiller C; Holzknecht M; Lechner I; Eisner D; Riepl L; Pamminger M; Henninger B; Mayr A; Schwaiger JP; Klug G; Bauer A; Metzler B; Reinstadler SJ
    Clin Res Cardiol; 2021 Jan; 110(1):61-71. PubMed ID: 32296969
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Association of plasma interleukin-6 with infarct size, reperfusion injury, and adverse remodelling after ST-elevation myocardial infarction.
    Tiller C; Reindl M; Holzknecht M; Lechner I; Schwaiger J; Brenner C; Mayr A; Klug G; Bauer A; Metzler B; Reinstadler SJ
    Eur Heart J Acute Cardiovasc Care; 2022 Feb; 11(2):113-123. PubMed ID: 34849677
    [TBL] [Abstract][Full Text] [Related]  

  • 67. G-CSF for Extensive STEMI.
    Achilli F; Pontone G; Bassetti B; Squadroni L; Campodonico J; Corrada E; Facchini C; Mircoli L; Esposito G; Scarpa D; Pidello S; Righetti S; Di Gennaro F; Guglielmo M; Muscogiuri G; Baggiano A; Limido A; Lenatti L; Di Tano G; Malafronte C; Soffici F; Ceseri M; Maggiolini S; Colombo GI; Pompilio G;
    Circ Res; 2019 Jul; 125(3):295-306. PubMed ID: 31138020
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impact of left ventricular hypertrophy on myocardial injury in patients with ST-segment elevation myocardial infarction.
    Stiermaier T; Pöss J; Eitel C; de Waha S; Fuernau G; Desch S; Thiele H; Eitel I
    Clin Res Cardiol; 2018 Nov; 107(11):1013-1020. PubMed ID: 29766285
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial.
    Najjar SS; Rao SV; Melloni C; Raman SV; Povsic TJ; Melton L; Barsness GW; Prather K; Heitner JF; Kilaru R; Gruberg L; Hasselblad V; Greenbaum AB; Patel M; Kim RJ; Talan M; Ferrucci L; Longo DL; Lakatta EG; Harrington RA;
    JAMA; 2011 May; 305(18):1863-72. PubMed ID: 21558517
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Safety of early discharge in low risk patients after acute ST-segment elevation myocardial infarction, treated with primary percutaneous coronary intervention. Open label, randomized trial.
    Novobilsky K; Stipal R; Cerny P; Horak I; Kaucak V; Mrozek J; Vaclavik J; Kryza R
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Feb; 163(1):61-66. PubMed ID: 30181666
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prognostic Stratification of Patients With ST-Segment-Elevation Myocardial Infarction (PROSPECT): A Cardiac Magnetic Resonance Study.
    Pontone G; Guaricci AI; Andreini D; Ferro G; Guglielmo M; Baggiano A; Fusini L; Muscogiuri G; Lorenzoni V; Mushtaq S; Conte E; Annoni A; Formenti A; Mancini ME; Carità P; Verdecchia M; Pica S; Fazzari F; Cosentino N; Marenzi G; Rabbat MG; Agostoni P; Bartorelli AL; Pepi M; Masci PG
    Circ Cardiovasc Imaging; 2017 Nov; 10(11):. PubMed ID: 29146587
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Complete Versus Lesion-Only Primary PCI: The Randomized Cardiovascular MR CvLPRIT Substudy.
    McCann GP; Khan JN; Greenwood JP; Nazir S; Dalby M; Curzen N; Hetherington S; Kelly DJ; Blackman DJ; Ring A; Peebles C; Wong J; Sasikaran T; Flather M; Swanton H; Gershlick AH
    J Am Coll Cardiol; 2015 Dec; 66(24):2713-2724. PubMed ID: 26700834
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Residual Myocardial Iron Following Intramyocardial Hemorrhage During the Convalescent Phase of Reperfused ST-Segment-Elevation Myocardial Infarction and Adverse Left Ventricular Remodeling.
    Bulluck H; Rosmini S; Abdel-Gadir A; White SK; Bhuva AN; Treibel TA; Fontana M; Ramlall M; Hamarneh A; Sirker A; Herrey AS; Manisty C; Yellon DM; Kellman P; Moon JC; Hausenloy DJ
    Circ Cardiovasc Imaging; 2016 Oct; 9(10):e004940. PubMed ID: 27894068
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Study design for the "effect of METOprolol in CARDioproteCtioN during an acute myocardial InfarCtion" (METOCARD-CNIC): a randomized, controlled parallel-group, observer-blinded clinical trial of early pre-reperfusion metoprolol administration in ST-segment elevation myocardial infarction.
    Ibanez B; Fuster V; Macaya C; Sánchez-Brunete V; Pizarro G; López-Romero P; Mateos A; Jiménez-Borreguero J; Fernández-Ortiz A; Sanz G; Fernández-Friera L; Corral E; Barreiro MV; Ruiz-Mateos B; Goicolea J; Hernández-Antolín R; Acebal C; García-Rubira JC; Albarrán A; Zamorano JL; Casado I; Valenciano J; Fernández-Vázquez F; de la Torre JM; Pérez de Prado A; Iglesias-Vázquez JA; Martínez-Tenorio P; Iñiguez A
    Am Heart J; 2012 Oct; 164(4):473-480.e5. PubMed ID: 23067904
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of infarct location and size on clinical outcome after ST-elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Reindl M; Holzknecht M; Tiller C; Lechner I; Schiestl M; Simma F; Pamminger M; Henninger B; Mayr A; Klug G; Bauer A; Metzler B; Reinstadler SJ
    Int J Cardiol; 2020 Feb; 301():14-20. PubMed ID: 31761400
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With ST-Segment Elevation Myocardial Infarction and Left Ventricular Dysfunction.
    Fernández-Avilés F; Sanz-Ruiz R; Bogaert J; Casado Plasencia A; Gilaberte I; Belmans A; Fernández-Santos ME; Charron D; Mulet M; Yotti R; Palacios I; Luque M; Sádaba R; San Román JA; Larman M; Sánchez PL; Sanchís J; Jiménez MF; Claus P; Al-Daccak R; Lombardo E; Abad JL; DelaRosa O; Corcóstegui L; Bermejo J; Janssens S
    Circ Res; 2018 Aug; 123(5):579-589. PubMed ID: 29921651
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Gradual Versus Abrupt Reperfusion During Primary Percutaneous Coronary Interventions in ST-Segment-Elevation Myocardial Infarction (GUARD).
    Sezer M; Escaned J; Broyd CJ; Umman B; Bugra Z; Ozcan I; Sonsoz MR; Ozcan A; Atici A; Aslanger E; Sezer ZI; Davies JE; van Royen N; Umman S
    J Am Heart Assoc; 2022 May; 11(10):e024172. PubMed ID: 35574948
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.
    Ezekowitz JA; Armstrong PW; Granger CB; Theroux P; Stebbins A; Kim RJ; Patel MR
    Am Heart J; 2010 Aug; 160(2):272-8. PubMed ID: 20691832
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Early or deferred cardiovascular magnetic resonance after ST-segment-elevation myocardial infarction for effective risk stratification.
    Masci PG; Pavon AG; Pontone G; Symons R; Lorenzoni V; Francone M; Zalewski J; Barison A; Guglielmo M; Aquaro GD; Galea N; Muscogiuri G; Muller O; Carbone I; Baggiano A; Iglesias JF; Nessler J; Andreini D; Camici PG; Claus P; de Luca L; Agati L; Janssens S; Schwitter J; Bogaert J
    Eur Heart J Cardiovasc Imaging; 2020 Jun; 21(6):632-639. PubMed ID: 31326993
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.